Position in ABT
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$7,286,149
+$183,131 QoQ
Shares Held
80,297
+16.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
#583
of 2,959 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Beaumont Financial Advisors, LLC holds $8,469,317 across 2 Medical Devices names. ABT ranks #1 (86.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
This page
|
80,297 | $7,286,149 | |
| 2 | SYK |
Stryker Corp
|
3,758 | $1,183,168 |
All Filings in ABT
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,286,149 | 80,297 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $7,103,018 | 69,183 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,950,454 | 23,549 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $2,739,206 | 20,451 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $2,672,324 | 19,648 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,728,212 | 20,567 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $8,312,793 | 73,493 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $8,392,048 | 73,608 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $7,682,066 | 73,930 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $8,215,117 | 72,278 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $7,785,691 | 70,734 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $6,963,321 | 71,898 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $7,898,717 | 72,452 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $7,392,486 | 73,005 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $8,189,675 | 74,594 | Shares | Sole | 2023-01-25 | |
| No filing history on record for this holder in this stock. | ||||||